Skip to content
Preprint · CC-BY via OpenAlex

Resveratrol targets PD-L1 glycosylation and dimerization to enhance antitumor T-cell immunity

Sara Verdura, Elisabet Cuyàs, Èric Cortada, Joan Brunet, Eugeni López‐Bonet, Begoña Martín-Castillo, Joaquim Bosch‐Barrera, José Antonio Encinar, Javier Abel Menéndez

Aging · 2020 · ▲ 154 citations

Abstract

-linked glycan decoration of PD-L1, thereby promoting the endoplasmic reticulum retention of a mannose-rich, abnormally glycosylated form of PD-L1. RSV was also predicted to interact with the inner surface of PD-L1 involved in the interaction with PD-1, almost perfectly occupying the target space of the small compound BMS-202 that binds to and induces dimerization of PD-L1. The ability of RSV to directly target PD-L1 interferes with its stability and trafficking, ultimately impeding its targeting to the cancer cell plasma membrane. Impedance-based real-time cell analysis (xCELLigence) showed that cytotoxic T-lymphocyte activity was notably exacerbated when cancer cells were previously exposed to RSV. This unforeseen immunomodulating mechanism of RSV might illuminate new approaches to restore T-cell function by targeting the PD-1/PD-L1 immunologic checkpoint with natural polyphenols.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.18632/aging.102646
Canonical
link ↗
Fetched
2026-11-12 MST

Cite this

APA
Verdura, S., Cuyàs, E., Cortada, �., Brunet, J., López‐Bonet, E., Martín-Castillo, B., Bosch‐Barrera, J., Encinar, J.A., &amp; Menéndez, J.A. (2020). Resveratrol targets PD-L1 glycosylation and dimerization to enhance antitumor T-cell immunity. <em>Aging</em>. https://doi.org/10.18632/aging.102646
Vancouver
Verdura S, Cuyàs E, Cortada �, Brunet J, López‐Bonet E, Martín-Castillo B, et al. Resveratrol targets PD-L1 glycosylation and dimerization to enhance antitumor T-cell immunity. Aging. 2020. doi:10.18632/aging.102646.
BibTeX
@unpublished{sara2020Resver, title = {Resveratrol targets PD-L1 glycosylation and dimerization to enhance antitumor T-cell immunity}, author = {Sara Verdura and Elisabet Cuyàs and Èric Cortada and Joan Brunet and Eugeni López‐Bonet and Begoña Martín-Castillo and Joaquim Bosch‐Barrera and José Antonio Encinar and Javier Abel Menéndez}, journal = {Aging}, year = {2020}, doi = {10.18632/aging.102646}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings